210 Actiskenan 30mg (Morphine IR)

210 Actiskenan 30mg (Morphine IR)

Actiskenan 30mg (Morphine IR) – 210 pills. Actiskenan is an immediate-release formulation of morphine sulfate, a full mu-opioid receptor agonist and the gold standard opioid analgesic. The 30 mg strength is considered a moderately high dose, typically used for severe acute pain or breakthrough cancer pain in opioid-tolerant patients. Immediate-release morphine has an onset of action of approximately 30–60 minutes and a duration of 4–6 hours. Critical safety information: This dose can cause significant respiratory depression, especially in opioid-naïve individuals. Risks include tolerance, physical dependence, constipation, nausea, and sedation. Concurrent use with benzodiazepines, alcohol, or other CNS depressants increases the risk of fatal overdose. Morphine is metabolized primarily to morphine-6-glucuronide (M6G), an active metabolite that accumulates in renal impairment, leading to prolonged effects and toxicity. Actiskenan is a controlled substance and should only be used under strict medical supervision.